Literature DB >> 8236275

Use of human hepatocyte cultures for drug metabolism studies.

A Guillouzo1, F Morel, O Fardel, B Meunier.   

Abstract

Among the in vitro models developed to investigate drug metabolism isolated hepatocytes have become the most powerful model. Human hepatocytes can be prepared from whole livers and surgical wedge biopsies. When placed in culture they retain their specific drug metabolizing activities including inducible cytochrome P450 enzymes for several days. Primary human hepatocyte cultures are now increasingly used for studying drug behavior during preclinical development, e.g. drug interactions, stereoselective drug metabolism and drug metabolic profiles. As a rule there is a good in vivo/in vitro correlation in drug biotransformation activity. The main metabolites found in vivo are recovered in vitro. However, quantitative differences are frequently observed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8236275     DOI: 10.1016/0300-483x(93)90065-z

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  13 in total

1.  Increase of cytochrome P-450 1A and glutathione transferase transcripts in cultured hepatocytes from dogs, monkeys, and humans after cryopreservation.

Authors:  G de Sousa; S Langouët; F Nicolas; G Lorenzon; M Placidi; R Rahmani; A Guillouzo
Journal:  Cell Biol Toxicol       Date:  1996-12       Impact factor: 6.691

2.  In vitro techniques for studying drug metabolism.

Authors:  F P Guengerich
Journal:  J Pharmacokinet Biopharm       Date:  1996-10

3.  Editor's Highlight: Modeling Compound-Induced Fibrogenesis In Vitro Using Three-Dimensional Bioprinted Human Liver Tissues.

Authors:  Leah M Norona; Deborah G Nguyen; David A Gerber; Sharon C Presnell; Edward L LeCluyse
Journal:  Toxicol Sci       Date:  2016-09-07       Impact factor: 4.849

4.  13th Meeting of the Scientific Group on Methodologies for the Safety Evaluation of Chemicals (SGOMSEC): alternative testing methodologies for organ toxicity.

Authors:  H Spielmann; N P Bochkov; L Costa; L Gribaldo; A Guillouzo; J J Heindel; M Karol; R Parchment; W Pfaller; P P Peraita; T Zacharewski
Journal:  Environ Health Perspect       Date:  1998-04       Impact factor: 9.031

5.  Potential inhibition of cytochrome P450 3A4 by propofol in human primary hepatocytes.

Authors:  Li-Qun Yang; Wei-Feng Yu; Yun-Fei Cao; Bin Gong; Qing Chang; Guang-Shun Yang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

6.  Developmental changes in hepatic antioxidant capacity are age-and sex-dependent.

Authors:  Shogo J Miyagi; Isaac W Brown; Jessica M-L Chock; Abby C Collier
Journal:  J Pharmacol Sci       Date:  2009-12       Impact factor: 3.337

Review 7.  Acquisition and use of human in vitro liver preparations.

Authors:  A Guillouzo
Journal:  Cell Biol Toxicol       Date:  1995-08       Impact factor: 6.691

8.  Relationships between in vitro and in vivo biotransformation of drugs in humans and animals: pharmaco-toxicological consequences.

Authors:  G de Sousa; N Florence; B Vallès; P Coassolo; R Rahmani
Journal:  Cell Biol Toxicol       Date:  1995-08       Impact factor: 6.691

9.  Comparison of the stability of some major cytochrome P450 and conjugation reactions in rat, dog and human hepatocyte monolayers.

Authors:  G Ubeaud; C D Schiller; F Hurbin; D Jaeck; P Coassolo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Jan-Jun       Impact factor: 2.569

10.  Fluorometric evaluation of CYP3A4 expression using improved transgenic HepaRG cells carrying a dual-colour reporter for CYP3A4 and CYP3A7.

Authors:  Takafumi Ueyama; Saori Tsuji; Takemi Sugiyama; Masako Tada
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.